The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa
Open accessAbstract
IMPORTANCE: Hidradenitis suppurativa (HS) is a common inflammatory skin disease. The disease has been associated with cardiovascular (CV) risk factors, but the risk of CV disease in patients with HS is unknown. OBJECTIVE: To investigate CV risk in patients with HS. DESIGN, SETTING, AND PARTICIPANTS: A population-based cohort study was conducted from January 1, 1997, to December 31, 2011, using individual-level linkage of nationwide administrative registers. In a study population of 35 368 Danish individuals, 5964 patients aged 18 years or older with a hospital-based diagnosis of HS (cases) were matched 1:5 on age, sex, and calendar time with 29 404 individuals serving as controls. MAIN OUTCOMES AND MEASURES: Outcomes were myocardial infarction (MI), stroke, CV-associated death, major adverse CV events (MACEs), and all-cause mortality. Incidence rate ratios (IRRs) were estimated by Poisson regression. RESULTS: The 5964 patients with HS had a mean (SD) age of 37.7 (11.7) years; 4346 (72.9%) were women. In this sample, a total of 62 (42 749.0 person-years) MIs, 74 (42 647.8 person-years) ischemic strokes, 63 (42 941.7 person-years) CV-associated deaths, 169 (42 463.5 person-years) MACEs, and 231 (42 941.7 person-years) all-cause deaths occurred during follow-up. Adjusted (age, sex, socioeconomic status, smoking, comorbidity, and medication) IRRs (95% CIs) were 1.57 (1.14-2.17) for MI, 1.33 (1.01-1.76) for ischemic stroke, 1.95 (1.42-2.67) for CV-associated death, 1.53 (1.27-1.86) for MACEs, and 1.35 (1.15-1.59) for all-cause mortality. When patients with severe psoriasis were used as controls, the adjusted IRRs in patients with HS were 1.00 (0.74-1.35) for MI, 0.93 (0.71-1.22) for ischemic stroke, 1.58 (1.17-2.12) for CV-associated death, 1.08 (0.90-1.29) for MACEs, and 1.09 (0.94-1.28) for all-cause mortality. CONCLUSIONS AND RELEVANCE: Hidradenitis suppurativa was associated with a significantly increased risk of adverse CV outcomes and all-cause mortality independent of measured confounders. The risk of CV-associated death was higher in patients with HS compared with the risk in those with severe psoriasis. The results call for increased awareness of this association and for studies of its clinical consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
The Danish Civil Registration System as a tool in epidemiology
Schmidt, M., Pedersen, L., & Sørensen, H. T. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9930-3 · Cited by 3,441
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.08.012 · Cited by 2,698
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
The Danish Register of Causes of Death
Helweg-Larsen, K. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399958 · Cited by 1,732
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
Self-citationEuropean S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Danish registers on personal income and transfer payments
Baadsgaard, M., & Quitzau, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811405098 · Cited by 968
Jemec, G. B. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1014163 · Cited by 817
The Danish prescription registries.
Gaist, D., Sørensen, H. T., & Hallas, J. (1997) · PubMed · Cited by 570
van der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472
Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Madsen, M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00591-7 · Cited by 460
Ahlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Self-citationExpression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Schlapbach, C., Hänni, T., Yawalkar, N., & Hunger, R. E. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.010 · Cited by 425
Lindhardsen, J., Ahlehoff, O., Gislason, G. H., Madsen, O. R., Olesen, J. B., Torp-Pedersen, C., & Hansen, P. R. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143396 · Cited by 405
Self-citationQuality of life impairment in hidradenitis suppurativa: A study of 61 cases
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.061 · Cited by 369
Validity of Stroke Diagnoses in a National Register of Patients
Krarup, L.-H., Boysen, G., Janjua, H., Prescott, E., & Truelsen, T. (2007) · Neuroepidemiology · doi:10.1159/000102143 · Cited by 366
Morbidity in patients with hidradenitis suppurativa
Von Der Werth, J. M., & Jemec, G. B. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04137.x · Cited by 344
Shlyankevich, J., Chen, A. J., Kim, G. E., & Kimball, A. B. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.09.012 · Cited by 316
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
Kelly, G., Hughes, R., McGarry, T., Born, M., Adamzik, K., Fitzgerald, R., Lawlor, C., Tobin, A. M., Sweeney, C. M., & Kirby, B. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14075 · Cited by 306
Depression in patients with hidradenitis suppurativa
Onderdijk, A. J., van der Zee, H. H., Esmann, S., Lophaven, S., Dufour, D. N., Jemec, G. B. E., & Boer, J. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04468.x · Cited by 271
Kristensen, S. L., Ahlehoff, O., Lindhardsen, J., Erichsen, R., Jensen, G. V., Torp-Pedersen, C., Nielsen, O. H., Gislason, G. H., & Hansen, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056944 · Cited by 249
Self-citationComorbidities of hidradenitis suppurativa (acne inversa)
Fimmel, S., & Zouboulis, C. C. (2010) · Dermato-Endocrinology · doi:10.4161/derm.2.1.12490 · Cited by 245
Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments
van der Zee, H. H., Laman, J. D., Boer, J., & Prens, E. P. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01552.x · Cited by 205
Tzellos, T., Zouboulis, C. C., Gulliver, W., Cohen, A. D., Wolkenstein, P., & Jemec, G. B. E. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14024 · Cited by 191
Medical comorbidity associated with psoriasis in adults: a population-based study
Yang, Y.-W., Keller, J. J., & Lin, H.-C. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10494.x · Cited by 176
Matusiak, L., Bieniek, A., & Szepietowski, J. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0749 · Cited by 172
Charlson, F., Moran, A. E., Freedman, G., Norman, R. E., Stapelberg, N. J. C., Baxter, A. J., Vos, T., & Whiteford, H. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-250 · Cited by 160
Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
Dufour, D., Emtestam, L., & Jemec, G. B. E. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-131994 · Cited by 152
van der Zee, H. H., van der Woude, C. J., Florencia, E. F., & Prens, E. P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09430.x · Cited by 151
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study
Egeberg, A., Mallbris, L., Gislason, G., Skov, L., & Hansen, P. R. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.350 · Cited by 133
Self-citationRichette, P., Moltó, A., Viguier, M., Dawidowicz, K., Hayem, G., Nassif, A., Wendling, D., Aubin, F., Lioté, F., & Bachelez, H. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130977 · Cited by 129
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Coumbe, A., PRITZKER, M. R., & Duprez, D. A. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.08.013 · Cited by 81
An overview of developing TNF-α targeted therapy for the treatment of psoriasis
Campa, M., Ryan, C., & Menter, A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1076793 · Cited by 37
Decreased Number of Circulating Endothelial Progenitor Cells in Hidradenitis Suppurativa Patients
Matusiak, Ł., Batycka-Baran, A., Bieniek, A., & Szepietowski, J. C. (2015) · Dermatology · doi:10.1159/000371877 · Cited by 9
Cited by
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Goldburg, S. R., Strober, B. E., & Payette, M. J. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.090 · Cited by 486
Garg, A., Neuren, E., Cha, D., Kirby, J. S., Ingram, J. R., Jemec, G. B. E., Esmann, S., Thorlacius, L., Villumsen, B., Marmol, V. D., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.06.1301 · Cited by 291
Zouboulis, C. C., Bechara, F. G., Dickinson‐Blok, J. L., Gulliver, W., Horváth, B., Hughes, R., Kimball, A. B., Kirby, B., Martorell, A., Podda, M., et al. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15233 · Cited by 259
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
Napolitano, M., Megna, M., Timoshchuk, E., Patruno, C., Balato, N., Fabbrocini, G., & Monfrecola, G. (2017) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s111019 · Cited by 253
Metadata
- Authors
- Egeberg, A., Gislason, G. H., & Hansen, P. R.
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-01
- Volume
- 152
- Issue
- 4
- Pages
- 429
- ISSN
- 2168-6068 (ISSN-L)
- OpenAlex
- W2276432228
- Cited by
- 265
- References
- 40
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.